CSO letter to ViiV calling for access to HIV PrEP drug CAB-LA

Civil society organisations (CSOs) sent this open letter, titled “Accelerating the end of AIDS through access to game-changing new health technologies”, to the CEO of ViiV Healthcare, calling for urgent global access to long-acting injectable cabotegravir (CAB-LA) for immediate use in HIV prevention (pre-exposure prophylaxis, PrEP) for people at high risk of infection.